Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6276
PUT
Denali Therapeutics
DNLI
$3.9B
| $1.2M | ﹤0.01% |
14,300
+7,400
| +107% | +$447K |
|
6277
PUT
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.32B
| $1.2M | ﹤0.01% |
18,200
-19,500
| -52% | -$971K |
|
6278
PUT
Regenxbio
RGNX
$737M
| $1.2M | ﹤0.01% |
26,400
+9,600
| +57% | +$335K |
|
6279
CALL
Boot Barn
BOOT
$4.86B
| $1.2M | ﹤0.01% |
27,600
-16,100
| -37% | -$606K |
|
6280
CALL
COPT Defense Properties
CDP
$4.17B
| $1.2M | ﹤0.01% |
+45,900
| New | +$1.16M |
|
6281
PUT
Compass Minerals
CMP
$1.1B
| $1.2M | ﹤0.01% |
19,400
-7,900
| -29% | -$490K |
|
6282
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$243M
| $1.2M | ﹤0.01% |
39,485
-158,760
| -80% | -$4.69M |
|
6283
CALL
Team
TISI
$104M
| $1.2M | ﹤0.01% |
+10,960
| New | +$901K |
|
6284
CALL
Ameren
AEE
$30.3B
| $1.19M | ﹤0.01% |
15,300
+8,000
| +110% | +$641K |
|
6285
PUT
MBIA
MBI
$253M
| $1.19M | ﹤0.01% |
181,500
-63,300
| -26% | -$412K |
|
6286
PUT
TotalEnergies
TTE
$196B
| $1.19M | ﹤0.01% |
28,500
-50,100
| -64% | -$1.93M |
|
6287
PUT
Travere Therapeutics
TVTX
$5.98B
| $1.19M | ﹤0.01% |
+43,800
| New | +$1.02M |
|
6288
PUT
Vanguard Energy ETF
VDE
$10.7B
| $1.19M | ﹤0.01% |
23,000
-22,800
| -50% | -$1.07M |
|
6289
CALL
Tronox
TROX
$902M
| $1.19M | ﹤0.01% |
81,500
-12,300
| -13% | -$143K |
|
|
VIEW
6290
CALL
DELISTED
View, Inc. Class A Common Stock
VIEW
| $1.19M | ﹤0.01% |
+1,803
| New | +$1.12M |
|
|
MIDF
6291
DELISTED
iShares MSCI USA Mid-Cap Multifactor ETF
MIDF
| $1.19M | ﹤0.01% |
37,637
+25,788
| +218% | +$766K |
|
6292
Direxion Daily Aerospace & Defense Bull 3X ETF
DFEN
$434M
| $1.19M | ﹤0.01% |
70,437
-98,122
| -58% | -$1.37M |
|
6293
Vanguard High Dividend Yield ETF
VYM
$83.7B
| $1.19M | ﹤0.01% |
13,021
-43,095
| -77% | -$3.74M |
|
6294
PUT
Liberty Global Class C
LBTYK
$3.46B
| $1.19M | ﹤0.01% |
50,300
+29,800
| +145% | +$646K |
|
6295
State Street Communication Services Select Sector SPDR ETF
XLC
$22.4B
| $1.19M | ﹤0.01% |
17,641
-164,275
| -90% | -$10.5M |
|
|
SRC
6296
CALL
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $1.19M | ﹤0.01% |
29,600
-9,000
| -23% | -$324K |
|
6297
CALL
AMN Healthcare
AMN
$1.33B
| $1.19M | ﹤0.01% |
17,400
-35,400
| -67% | -$2.31M |
|
6298
Goldman Sachs BDC
GSBD
$1.1B
| $1.19M | ﹤0.01% |
62,121
+42,711
| +220% | +$734K |
|
|
MTLS
6299
CALL
Materialise
MTLS
$391M
| $1.19M | ﹤0.01% |
+21,900
| New | +$975K |
|
6300
Simulations Plus
SLP
$371M
| $1.19M | ﹤0.01% |
+16,505
| New | +$1.09M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.